Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany
Autor: | Christensen, Hannah, Irving, Tom, Koch, Judith, Trotter, Caroline L., Ultsch, Bernhard, Weidemann, Felix, Wichmann, Ole, Hellenbrand, Wiebke |
---|---|
Zdroj: | In Vaccine 17 June 2016 34(29):3412-3419 |
Databáze: | ScienceDirect |
Externí odkaz: |